Mometasone Furoate Market Share

North American Market Statistics

North America industry is likely to hold largest revenue share of 47% by 2037. The landscape growth in the region is expected to grow, credited to the surge in the number of awareness campaigns regarding psoriasis and the high prevalence of skin conditions like eczema in the region. According to a report, in North America, 7.5 million individuals suffer from psoriasis every year.

In addition, there has been a surge for skincare and dermatological health, coupled with increasing demand for products like mometasone, as new and improved mometasone formulations have also been made, which will further drive the industrial growth rate, hence augmenting the mometasone furoate market revenue share.

European Market Analysis

The European region will also encounter a huge influence on the mometasone furoate market size expansion in the coming years and will account for the second position owing to the gain in approvals for mometasone spray, coupled with the aging population in many European countries and the increasing need for such products.

Moreover, the presence of e-commerce and online pharmacies has made it easier for people to access and purchase more mometasone-furoate products. In addition, the increasing investments in healthcare industries and the availability of advanced medical facilities in Europe have also supported the growth of the mometasone furoate market.